NN Investment Partners Holdings N.V. grew its holdings in AmerisourceBergen Co. (NYSE:ABC) by 12.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,037 shares of the company’s stock after purchasing an additional 1,762 shares during the quarter. NN Investment Partners Holdings N.V.’s holdings in AmerisourceBergen were worth $1,567,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Nachman Norwood & Parrott Inc acquired a new stake in shares of AmerisourceBergen in the third quarter valued at approximately $27,000. Northwest Investment Counselors LLC acquired a new stake in shares of AmerisourceBergen in the third quarter valued at approximately $30,000. Simon Quick Advisors LLC boosted its position in AmerisourceBergen by 890.9% during the third quarter. Simon Quick Advisors LLC now owns 327 shares of the company’s stock worth $32,000 after acquiring an additional 294 shares during the last quarter. Prestige Wealth Management Group LLC boosted its position in AmerisourceBergen by 45.8% during the third quarter. Prestige Wealth Management Group LLC now owns 328 shares of the company’s stock worth $31,000 after acquiring an additional 103 shares during the last quarter. Finally, Planned Solutions Inc. acquired a new stake in AmerisourceBergen during the third quarter worth approximately $50,000. Institutional investors and hedge funds own 63.35% of the company’s stock.
In other news, EVP Robert P. Mauch sold 16,561 shares of the firm’s stock in a transaction on Wednesday, January 6th. The shares were sold at an average price of $105.06, for a total value of $1,739,898.66. Following the transaction, the executive vice president now owns 38,363 shares of the company’s stock, valued at approximately $4,030,416.78. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert P. Mauch sold 77,560 shares of the firm’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $98.02, for a total transaction of $7,602,431.20. Following the completion of the transaction, the executive vice president now directly owns 99,362 shares in the company, valued at approximately $9,739,463.24. The disclosure for this sale can be found here. Company insiders own 28.30% of the company’s stock.
NYSE:ABC opened at $106.27 on Thursday. The company has a quick ratio of 0.60, a current ratio of 0.98 and a debt-to-equity ratio of 0.91. The company has a market cap of $21.71 billion, a P/E ratio of -6.33, a P/E/G ratio of 1.13 and a beta of 0.57. AmerisourceBergen Co. has a fifty-two week low of $72.06 and a fifty-two week high of $112.88. The firm’s 50 day moving average is $104.40 and its two-hundred day moving average is $100.84.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Wednesday, February 3rd. The company reported $2.18 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.94 by $0.24. The company had revenue of $52.50 billion for the quarter, compared to the consensus estimate of $50.49 billion. AmerisourceBergen had a negative net margin of 1.80% and a positive return on equity of 65.93%. AmerisourceBergen’s revenue was up 9.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.76 earnings per share. Research analysts forecast that AmerisourceBergen Co. will post 8.38 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Friday, February 12th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date of this dividend is Thursday, February 11th. AmerisourceBergen’s dividend payout ratio is currently 22.28%.
A number of analysts recently issued reports on ABC shares. Bank of America upgraded shares of AmerisourceBergen from an “underperform” rating to a “neutral” rating in a research report on Wednesday, January 6th. Evercore ISI upgraded shares of AmerisourceBergen from an “in-line” rating to an “outperform” rating in a research report on Thursday, February 4th. Mizuho raised their target price on shares of AmerisourceBergen from $104.00 to $114.00 and gave the stock a “neutral” rating in a research report on Tuesday. They noted that the move was a valuation call. Credit Suisse Group raised their target price on shares of AmerisourceBergen from $123.00 to $127.00 and gave the stock an “outperform” rating in a research report on Friday, February 5th. Finally, TheStreet lowered shares of AmerisourceBergen from a “b+” rating to a “d” rating in a research report on Thursday, November 5th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. AmerisourceBergen currently has a consensus rating of “Buy” and an average target price of $120.10.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Article: What is a dividend reinvestment plan?
Receive News & Ratings for AmerisourceBergen Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AmerisourceBergen and related companies with MarketBeat.com’s FREE daily email newsletter.